International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

BHR in PLO Gel (Benadryl, Haldol, and Reglan in Pluronic Lecithin Organogel)

Author(s): Allen Loyd V Jr

Issue: Jul/Aug 2021 - Volume 25, Number 4
View All Articles in Issue

Page(s): 322

BHR in PLO Gel (Benadryl, Haldol, and Reglan in Pluronic Lecithin Organogel) Page 1

Download in electronic PDF format for $75

Abstract: A formulation for preparing BHR in PLO Gel (Benadryl, Haldol, and Reglan in Pluronic Lecithin Organogel). Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen Jr., PhD, RPh, formulation, BHR in PLO gel, benadryl, diphenhydramine, haldol, haloperidol, reglan, metoclopramide hydrochloride, Pluronic lecithin organogel, topical preparations, nausea, vomiting, emesis

Related Categories: FORMULATIONS, GASTROENTEROLOGY, DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
BHR in PLO Gel (Benadryl, Haldol, and Reglan in Pluronic Lecithin Organogel) Allen Loyd V Jr	Jul/Aug 2021 Pg. 322
The History of Pluronic Lecithin Organogel: An Interview With Marty Jones, BSPharm, FACA, FIACP Allen Loyd V Jr	May/Jun 2003 Pg. 180-183
Pluronic Lecithin Organogel for Local Delivery of Anti-Inflammatory Drugs Frankum James, Ramsay Dale, Das Nandita G, Das Sudip K	Mar/Apr 2004 Pg. 101-105
Effect of Formulation pH on Transdermal Penetration of Antiemetics Formulated in Poloxamer Lecithin Organogel Woodall Rachel, Arnold John J, McKay Doug, Abill C Scott	May/Jun 2013 Pg. 247-253
Percutaneous Absorption of Lorazepam, Diphenhydramine Hydrochloride, and Haloperidol from ABH Gel Dahal Amit, Neupane Rabin, Boddu Sai HS, Renukuntla Jwala, Khupse Rahul, Dudley Richard	Mar/Apr 2020 Pg. 168-175
Oxycodone Hydrochloride 10 mg/mL in Pluronic Lecithin Organogel Allen Loyd V Jr	May/Jun 2009 Pg. 245
Bioavailability of Promethazine in a Topical Pluronic Lecithin Organogel: A Pilot Study Glisson James K, Wood Rebecca L, Kyle Patrick B, Cleary John D	May/Jun 2005 Pg. 242-246
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr	Nov/Dec 2003 Pg. 449-450
Morphine Sulfate 50 mg/mL in Pluronic Lecithin Organogel Allen Loyd V Jr	May/Jun 2009 Pg. 244
The Use of Pluronic Lecithin Organogels in the Transdermal Delivery of Drugs Bramwell Bethany L, Williams LaVonn A	Jan/Feb 2012 Pg. 62-63
Preparation and In Vitro Evaluation of a Pluronic Lecithin Organogel Containing Ricinoleic Acid for Transdermal Delivery Boddu Sai HS, Bonam Sindhu Prabha, Wei Yangjie, Alexander Kenneth	May/Jun 2014 Pg. 256-261
Physical Stability and Release Profile of Compounded Gabapentin Containing Pluronic Lecithin Organogel for Neuropathic Pain Management Hong Eun Ji, Sumanasekera Wasana, Le Uyen Minh	Jan/Feb 2022 Pg. 65-71
Amitriptyline 4%, Dextromethorphan Hydrobromide 20%, and Tramadol Hydrochloride 5% in Pluronic Lecithin Organogel Gel Allen Loyd V Jr	May/Jun 2011 Pg. 242
Ketoprofen 10%, Ibuprofen 10%, Cyclobenzaprine Hydrochloride 2%, and Piroxicam 2% in Pluronic Lecithin Organogel Gel Allen Loyd V Jr	May/Jun 2011 Pg. 245
Pluronic Lecithin Organogel (PLO Gel) Allen Loyd V Jr	Sep/Oct 1999 Pg. 389
Amitriptyline 4%, Dextromethorphan Hydrobromide 20%, and Tramadol Hydrochloride 5% in Pluronic Lecithin Organogel GEL Allen Loyd V Jr	Mar/Apr 2024 Pg. 130
Ketoprofen 10% in Pluronic Lecithin Organogel Allen Loyd V Jr	Jan/Feb 2019 Pg. 52
Amitriptyline Hydrochloride 2%, Baclofen 5%, Ketamine Hydrochloride 5%, Ketoprofen 10% in Pluronic Lecithin Organogel Allen Loyd V Jr	Nov/Dec 2010 Pg. 512
In Vitro Percutaneous Absorption of Ketoprofen and Testosterone: Comparison of Pluronic Lecithin Organogel vs. Pentravan Cream Lehman Paul A, Raney Sam G	May/Jun 2012 Pg. 248-252
Castor Oil 50% in Modified Pluronic Lecithin Organogel Gel Allen Loyd V Jr	Jul/Aug 2017 Pg. 313
Return to Top